Article
Peptide derived nanobody inhibits entry of SARS-CoV-2 variants
2022-04-21
Abstract excerpt
Emergence of the new escape mutants of the SARS-CoV-2 virus has escalated its penetration among the human population and has reinstated its status as a global pandemic. Therefore, developing effective antiviral therapy against emerging SARS variants and other viruses in a short period of time becomes essential. Blocking the SARS-CoV-2 entry into human host cells by disrupting the spike glycoprotein-ACE2 interactio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 29d348f3-d7da-5c6f-aff1-4df888fb1dee
- DOI
- 10.1101/2022.04.21.489021
